S&P 500   4,075.06 (-0.12%)
DOW   34,360.12 (-0.66%)
QQQ   292.83 (-0.18%)
AAPL   147.45 (-0.39%)
MSFT   253.30 (-0.72%)
META   119.70 (+1.35%)
GOOGL   100.89 (-0.10%)
AMZN   96.10 (-0.46%)
TSLA   194.47 (-0.12%)
NVDA   170.57 (+0.79%)
NIO   12.33 (-3.52%)
BABA   86.27 (-1.47%)
AMD   76.87 (-0.98%)
T   19.16 (-0.62%)
MU   55.50 (-3.73%)
CGC   3.65 (+0.83%)
F   14.12 (+1.58%)
GE   85.71 (-0.30%)
DIS   97.74 (-0.13%)
AMC   8.27 (+14.38%)
PYPL   78.39 (-0.03%)
PFE   50.56 (+0.86%)
NFLX   315.32 (+3.20%)
S&P 500   4,075.06 (-0.12%)
DOW   34,360.12 (-0.66%)
QQQ   292.83 (-0.18%)
AAPL   147.45 (-0.39%)
MSFT   253.30 (-0.72%)
META   119.70 (+1.35%)
GOOGL   100.89 (-0.10%)
AMZN   96.10 (-0.46%)
TSLA   194.47 (-0.12%)
NVDA   170.57 (+0.79%)
NIO   12.33 (-3.52%)
BABA   86.27 (-1.47%)
AMD   76.87 (-0.98%)
T   19.16 (-0.62%)
MU   55.50 (-3.73%)
CGC   3.65 (+0.83%)
F   14.12 (+1.58%)
GE   85.71 (-0.30%)
DIS   97.74 (-0.13%)
AMC   8.27 (+14.38%)
PYPL   78.39 (-0.03%)
PFE   50.56 (+0.86%)
NFLX   315.32 (+3.20%)
S&P 500   4,075.06 (-0.12%)
DOW   34,360.12 (-0.66%)
QQQ   292.83 (-0.18%)
AAPL   147.45 (-0.39%)
MSFT   253.30 (-0.72%)
META   119.70 (+1.35%)
GOOGL   100.89 (-0.10%)
AMZN   96.10 (-0.46%)
TSLA   194.47 (-0.12%)
NVDA   170.57 (+0.79%)
NIO   12.33 (-3.52%)
BABA   86.27 (-1.47%)
AMD   76.87 (-0.98%)
T   19.16 (-0.62%)
MU   55.50 (-3.73%)
CGC   3.65 (+0.83%)
F   14.12 (+1.58%)
GE   85.71 (-0.30%)
DIS   97.74 (-0.13%)
AMC   8.27 (+14.38%)
PYPL   78.39 (-0.03%)
PFE   50.56 (+0.86%)
NFLX   315.32 (+3.20%)
S&P 500   4,075.06 (-0.12%)
DOW   34,360.12 (-0.66%)
QQQ   292.83 (-0.18%)
AAPL   147.45 (-0.39%)
MSFT   253.30 (-0.72%)
META   119.70 (+1.35%)
GOOGL   100.89 (-0.10%)
AMZN   96.10 (-0.46%)
TSLA   194.47 (-0.12%)
NVDA   170.57 (+0.79%)
NIO   12.33 (-3.52%)
BABA   86.27 (-1.47%)
AMD   76.87 (-0.98%)
T   19.16 (-0.62%)
MU   55.50 (-3.73%)
CGC   3.65 (+0.83%)
F   14.12 (+1.58%)
GE   85.71 (-0.30%)
DIS   97.74 (-0.13%)
AMC   8.27 (+14.38%)
PYPL   78.39 (-0.03%)
PFE   50.56 (+0.86%)
NFLX   315.32 (+3.20%)
NASDAQ:QTRX

Quanterix - QTRX Stock Forecast, Price & News

$13.29
-0.01 (-0.08%)
(As of 12/1/2022 12:21 PM ET)
Add
Compare
Today's Range
$13.12
$13.57
50-Day Range
$8.06
$13.30
52-Week Range
$6.31
$44.86
Volume
2,897 shs
Average Volume
421,902 shs
Market Capitalization
$492.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.00

Quanterix MarketRank™ Forecast

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
95.6% Upside
$26.00 Price Target
Short Interest
Healthy
3.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.92mentions of Quanterix in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.64) to ($1.52) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.21 out of 5 stars

Medical Sector

546th out of 1,047 stocks

Analytical Instruments Industry

19th out of 28 stocks

QTRX stock logo

About Quanterix (NASDAQ:QTRX) Stock

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Stock News Headlines

Analysts Set Quanterix Co. (NASDAQ:QTRX) Price Target at $23.60
Quanterix’ Third Quarter 2022 Earnings Conference Call
Quanterix Corporation: Selling For Less Than Cash Value
Quanterix Corporation (QTRX)
See More Headlines
Receive QTRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quanterix and its competitors with MarketBeat's FREE daily newsletter.

QTRX Company Calendar

Last Earnings
11/08/2022
Today
12/01/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/07/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:QTRX
Fax
N/A
Employees
460
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$26.00
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+95.6%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Net Income
$-57,690,000.00
Pretax Margin
-89.29%

Debt

Sales & Book Value

Annual Sales
$110.56 million
Book Value
$10.06 per share

Miscellaneous

Free Float
34,016,000
Market Cap
$492.53 million
Optionable
Not Optionable
Beta
1.32

Key Executives

  • Dr. Masoud Toloue Ph.D. (Age 42)
    Pres, CEO & Director
    Comp: $795.41k
  • Dr. David R. Walt Ph.D. (Age 69)
    Co-Founder, Chairman of Scientific Advisory Board & Independent Director
    Comp: $41k
  • Mr. Michael A. Doyle (Age 66)
    CFO & Treasurer
    Comp: $490k
  • Mr. Bruce J. Bal (Age 63)
    VP of Operations, Service & Quality
  • Mr. Daniel Pikora (Age 47)
    Chief Operating Officer
  • Dr. David C. Duffy Ph.D. (Age 51)
    Sr. VP of R&D and CTO
  • David Panzerella
    VP of Sales
  • Dr. Mark T. Roskey Ph.D. (Age 62)
    Sr. VP of Strategic Partnerships
  • Ms. Mary Ellen Cortizas
    VP of Laboratory Services & CRO













QTRX Stock - Frequently Asked Questions

Should I buy or sell Quanterix stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quanterix in the last year. There are currently 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" QTRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QTRX, but not buy additional shares or sell existing shares.
View QTRX analyst ratings
or view top-rated stocks.

What is Quanterix's stock price forecast for 2023?

7 analysts have issued 1-year price targets for Quanterix's stock. Their QTRX share price forecasts range from $12.00 to $60.00. On average, they anticipate the company's stock price to reach $26.00 in the next twelve months. This suggests a possible upside of 95.5% from the stock's current price.
View analysts price targets for QTRX
or view top-rated stocks among Wall Street analysts.

How have QTRX shares performed in 2022?

Quanterix's stock was trading at $42.40 at the beginning of the year. Since then, QTRX stock has decreased by 68.6% and is now trading at $13.30.
View the best growth stocks for 2022 here
.

When is Quanterix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our QTRX earnings forecast
.

How were Quanterix's earnings last quarter?

Quanterix Co. (NASDAQ:QTRX) issued its earnings results on Tuesday, November, 8th. The company reported ($0.40) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.42) by $0.02. The company earned $26.65 million during the quarter, compared to the consensus estimate of $22.56 million. Quanterix had a negative trailing twelve-month return on equity of 18.91% and a negative net margin of 89.24%.

What is Kevin Hrusovsky's approval rating as Quanterix's CEO?

15 employees have rated Quanterix Chief Executive Officer Kevin Hrusovsky on Glassdoor.com. Kevin Hrusovsky has an approval rating of 70% among the company's employees.

What other stocks do shareholders of Quanterix own?
When did Quanterix IPO?

(QTRX) raised $50 million in an IPO on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners served as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.23%), Frontier Capital Management Co. LLC (5.22%), Vanguard Group Inc. (4.91%), Platinum Investment Management Ltd. (3.12%), Ashford Capital Management Inc. (2.43%) and Portolan Capital Management LLC (2.05%). Insiders that own company stock include Amol Chaubal, David C Duffy, David C Duffy, David R Walt, Dawn Mattoon, E Kevin Hrusovsky, John J Fry, John J Fry, Marijn E Dekkers, Marijn E Dekkers, Mark T Roskey, Mark T Roskey, Martin D Madaus, Masoud Toloue and Michael A Doyle.
View institutional ownership trends
.

How do I buy shares of Quanterix?

Shares of QTRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $13.30.

How much money does Quanterix make?

Quanterix (NASDAQ:QTRX) has a market capitalization of $492.83 million and generates $110.56 million in revenue each year. The company earns $-57,690,000.00 in net income (profit) each year or ($2.66) on an earnings per share basis.

How many employees does Quanterix have?

The company employs 460 workers across the globe.

How can I contact Quanterix?

Quanterix's mailing address is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. The official website for the company is www.quanterix.com. The company can be reached via phone at (617) 301-9400 or via email at ir@quanterix.com.

This page (NASDAQ:QTRX) was last updated on 12/1/2022 by MarketBeat.com Staff